| Autor: |
Chevallard, Michel, Adinolfi, Antonella, Belloli, Laura, Casu, Cinzia, Di Cicco, Maria, Destefani, Chiara, Di Rosa, Bartolomeo, Gentile, Maria Giovanna, Filippini, Davide Antonio, Luisi, Angela, Muscarà, Marina, Schito, Emanuela, Ughi, Nicola, Verduci, Elisa, Vincenti, Emanuela Marta, Zoppini, Laura, Epis, Oscar Massimiliano |
| Předmět: |
|
| Zdroj: |
Clinical Rheumatology; Mar2023, Vol. 42 Issue 3, p923-928, 6p |
| Abstrakt: |
Seasonal influenza is a frequent cause of hospitalization and mortality among patients with systemic autoimmune diseases. Despite this evidence, vaccination coverage is generally much lower than the minimum 75% target proposed by the WHO. Therefore, an active campaign was implemented in the years 2019/2020 and 2020/2021 within the Rheumatology Department of the Niguarda Hospital (Milan, Italy) to improve the vaccination coverage in patients with inflammatory arthritis. This study aims to evaluate the vaccination coverage in the 2019/2020 and 2020/2021 (active campaigns) seasons and to compare these results with the 2018/2019 season. A monocenter observational study was conducted among adult patients with rheumatoid arthritis, spondylarthritis, or psoriatic arthropathy, who were referred to the Rheumatology Department of the Niguarda Hospital. Patients were given a questionnaire to investigate previous years' vaccination coverage and to propose an influenza vaccine for the 2020/2021 season. Compared with 2018/2019, a trend for increase in vaccination coverage was reported in 2019/2020 season (+ 10.7%, p = 0.055; 45.5% of coverage) and a statistically significant increase was reported in 2020/2021 (+ 31.2%, p < 0.001; 65.9% of coverage). The increase was also significant when comparing the 2020/2021 and 2019/2020 seasons (+ 20.5%, p < 0.001). The greatest increase in vaccination coverage was observed among under-65-year-old patients. Obtained results support the implementation of active vaccination campaigns to increase vaccination coverage among patients with systemic autoimmune diseases and highlight the importance of external factors (such as the COVID-19 pandemic) in directing the patient to adopt preventive measures to avoid infections and related complications. Key Points • Vaccination coverage is generally much lower than the minimum 75% target proposed by WHO among patients with systemic autoimmune diseases. • To improve the vaccination coverage, an active campaign was implemented in the years 2019/2020 and 2020/2021 within the Rheumatology Department of the Niguarda Hospital (Milan, Italy). • Compared with 2018/2019, a trend for increase in vaccination coverage was reported in 2019/2020 season (+ 10.7%, p = 0.055; 45.5% of coverage) and a significant increase was reported in 2020/2021 (+ 31.2%, p < 0.001; 65.9% of coverage) season. • Obtained results support the implementation of active vaccination campaigns to increase vaccination coverage among patients with systemic autoimmune diseases. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink